Q9H251 | SWISS-MODEL Repository

Q9H251 (CAD23_HUMAN) Homo sapiens (Human)

Cadherin-23 UniProtKB InterPro STRING Interactive Modelling

3354 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11)

It is possible new templates exist for this target since these models were created.

Available Structures

6 Experimental Structures

Description	PDB ID	Oligo-state	Range	Ligands
Solution structure of harmonin N terminal domain in complex with a internal peptide of cadherin23	2kbr SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q9Y6N9;	3183-3200
Assess
Solution structure of harmonin N terminal domain in complex with a exon68 encoded peptide of cadher…	2lsr SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q9Y6N9;	3212-3227
Assess
Solution structure of harmonin PDZ2 in complex with the carboxyl tail peptide of cadherin23	2kbs SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q9Y6N9;	3347-3354
Assess
Crystal Structure of Human Cadherin-23 EC6-8	5tfm SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	557-881	5×CA; 1×NA;
Assess
Crystal structure of human CDH23 EC21-23	5vvm SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	2176-2496	6×CA;
Assess
Crystal Structure of Human Cadherin-23 EC13-14	5wj8 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1310-1519	4×CA; 1×CL; 1×K;
Assess

12 SWISS-MODEL models

Template	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
6vg4.1.A	monomer	0.57	998-1626	2×CA;	29.59
Assess
6vg4.1.A	monomer	0.57	565-1200	2×CA;	29.01
Assess
6vg4.1.A	monomer	0.57	894-1519	1×CA;	27.64
Assess
6vg4.1.A	monomer	0.55	2118-2714	1×CA;	34.91
Assess
6vg1.1.B	monomer	0.55	782-1409	1×CA;	24.84
Assess
6vg4.1.A	monomer	0.55	876-1410	1×CA;	30.17
Assess
6e6b.1.A	monomer	0.53	1150-1719	5×CA;	32.30
Assess
6e6b.1.A	monomer	0.53	675-1307	5×CA;	26.86
Assess
6e6b.1.A	monomer	0.52	464-1096	4×CA;	30.67
Assess
6vg4.1.A	monomer	0.52	1837-2394	2×CA;	30.23
Assess
6vg1.1.A	monomer	0.52	446-985	1×CA;	32.37
Assess
6vg1.1.A	monomer	0.51	1135-1721	1×CA;	32.11
Assess

Model ID	Oligo-state	Avg pLDDT	Range	Trg-Mdl Seq Id (%)

Model ID	Oligo-state	Avg Confidence	Range	Trg-Mdl Seq id (%)

88 SWISS-MODEL models built on isoform sequence

Template	Isoform	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
Isoform 2	6vg4.1.A	monomer	0.58	892-1517	1×CA;	27.64
Assess
Isoform 2	6vg4.1.A	monomer	0.58	996-1624	2×CA;	29.76
Assess
Isoform 2	6vg4.1.A	monomer	0.57	563-1198	2×CA;	29.01
Assess
Isoform 2	6vg4.1.A	monomer	0.56	874-1408	1×CA;	30.17
Assess
Isoform 2	6vg1.1.B	monomer	0.56	780-1407	1×CA;	24.84
Assess
Isoform 2	6vg4.1.A	monomer	0.54	2116-2712	1×CA;	34.91
Assess
Isoform 2	6e6b.1.A	monomer	0.54	1148-1717	6×CA;	32.30
Assess
Isoform 2	6e6b.1.A	monomer	0.53	673-1305	5×CA;	26.86
Assess
Isoform 2	6vg1.1.A	monomer	0.52	1133-1719	1×CA;	32.11
Assess
Isoform 2	6vg1.1.A	monomer	0.52	444-983	1×CA;	32.37
Assess
Isoform 2	6e6b.1.A	monomer	0.52	462-1094	4×CA;	30.67
Assess
Isoform 2	1q55.1.A	monomer	0.51	999-1523	3×CA;	23.23
Assess
Isoform 3	6vg4.1.A	monomer	0.57	565-1200	2×CA;	29.01
Assess
Isoform 3	6vg1.1.A	monomer	0.57	675-1304	3×CA;	25.33
Assess
Isoform 3	6vg4.1.A	monomer	0.57	894-1518	1×CA;	27.69
Assess
Isoform 3	6vg4.1.A	monomer	0.57	998-1625	2×CA;	29.80
Assess
Isoform 3	6vg4.1.A	monomer	0.56	675-1305	5×CA;	26.39
Assess
Isoform 3	6vg1.1.A	monomer	0.56	894-1517	1×CA;	29.51
Assess
Isoform 3	6vg4.1.A	monomer	0.55	2117-2713	1×CA;	34.91
Assess
Isoform 3	6e6b.1.A	monomer	0.54	782-1411	1×CA;	25.49
Assess
Isoform 3	6e6b.1.A	monomer	0.53	1150-1718	6×CA;	32.30
Assess
Isoform 3	6vg1.1.A	monomer	0.52	446-985	1×CA;	32.37
Assess
Isoform 3	6vg4.1.A	monomer	0.52	1836-2393	2×CA;	30.23
Assess
Isoform 3	6e6b.1.A	monomer	0.52	464-1096	4×CA;	30.67
Assess
Isoform 4	6vg4.1.A	monomer	0.57	565-1200	2×CA;	29.01
Assess
Isoform 4	6vg1.1.A	monomer	0.57	675-1304	3×CA;	25.33
Assess
Isoform 4	6vg4.1.A	monomer	0.57	998-1626	2×CA;	29.59
Assess
Isoform 4	6vg4.1.A	monomer	0.57	894-1519	1×CA;	27.64
Assess
Isoform 4	6vg1.1.A	monomer	0.57	782-1409	1×CA;	24.84
Assess
Isoform 4	6vg4.1.A	monomer	0.56	675-1305	5×CA;	26.39
Assess
Isoform 4	6vg4.1.A	monomer	0.55	876-1410	1×CA;	30.17
Assess
Isoform 4	6vg4.1.A	monomer	0.55	2118-2714	1×CA;	34.91
Assess
Isoform 4	5dzv.1.A	monomer	0.54	1110-1626	4×CA;	29.53
Assess
Isoform 4	6e6b.1.A	monomer	0.54	1150-1719	5×CA;	32.30
Assess
Isoform 4	6vg1.1.A	monomer	0.52	1135-1721	1×CA;	32.11
Assess
Isoform 4	6vg1.1.A	monomer	0.52	446-985	1×CA;	32.37
Assess
Isoform 4	6e6b.1.A	monomer	0.52	464-1096	4×CA;	30.67
Assess
Isoform 4	6vg4.1.A	monomer	0.51	1837-2394	2×CA;	30.23
Assess
Isoform 5	6vg1.1.A	homo-2-mer	0.58	25-504	3×CA;	26.26
Assess
Isoform 5	5iry.1.A	homo-2-mer	0.57	40-491		22.56
Assess
Isoform 5	7a7d.1.K	monomer	0.57	40-503		25.06
Assess
Isoform 5	7a7d.1.H	monomer	0.56	40-503		25.06
Assess
Isoform 5	7a7d.1.A	monomer	0.54	40-503		21.17
Assess
Isoform 6	6vg4.1.A	monomer	0.59	39-663	2×CA;	26.16
Assess
Isoform 6	6vg4.1.A	monomer	0.59	240-882	2×CA;	31.92
Assess
Isoform 6	6vg1.1.A	homo-2-mer	0.57	40-662	1×CA;	26.21
Assess
Isoform 6	6e6b.1.A	homo-2-mer	0.56	464-1096	11×CA;	30.51
Assess
Isoform 6	6e6b.1.A	homo-2-mer	0.55	352-989	14×CA;	26.77
Assess
Isoform 6	3q2w.1.B	homo-2-mer	0.54	465-986	10×CA;	27.33
Assess
Isoform 6	6e6b.1.A	homo-2-mer	0.52	340-873	9×CA;	35.95
Assess
Isoform 6	1q55.1.A	monomer	0.51	566-1103	4×CA;	24.80
Assess
Isoform 6	1q55.1.A	monomer	0.51	134-669	4×CA;	23.15
Assess
Isoform 7	3q2v.1.A	homo-2-mer	0.57	63-601	4×CA;	22.57
Assess
Isoform 7	6e6b.1.A	homo-2-mer	0.56	60-714	7×CA;	27.21
Assess
Isoform 7	5t9t.1.A	homo-2-mer	0.55	166-715	6×CA;	27.17
Assess
Isoform 7	3q2w.1.B	homo-2-mer	0.53	167-711	4×CA;	25.20
Assess
Isoform 7	7a7d.1.H	monomer	0.53	168-712		22.98
Assess
Isoform 7	6c13.1.A	homo-2-mer	0.52	266-813		23.13
Assess
Isoform 7	7a7d.1.A	monomer	0.52	60-606		22.88
Assess
Isoform 7	5erd.1.A	homo-2-mer	0.52	61-608	2×CA;	22.64
Assess
Isoform 7	5erd.1.A	homo-2-mer	0.52	162-712		22.55
Assess
Isoform 7	7a7d.1.A	monomer	0.51	162-712		22.51
Assess
Isoform 7	7a7d.1.E	monomer	0.51	162-712		22.51
Assess
Isoform 7	7a7d.1.D	monomer	0.50	162-712		22.51
Assess
Isoform 8	6vg4.1.A	monomer	0.57	1002-1629	2×CA;	29.80
Assess
Isoform 8	6vg4.1.A	monomer	0.57	568-1203	2×CA;	29.01
Assess
Isoform 8	6vg4.1.A	monomer	0.57	897-1522	1×CA;	27.64
Assess
Isoform 8	6vg4.1.A	monomer	0.56	2121-2717	1×CA;	34.91
Assess
Isoform 8	6vg4.1.A	monomer	0.55	879-1413	1×CA;	30.17
Assess
Isoform 8	6vg1.1.B	monomer	0.55	785-1412	1×CA;	24.84
Assess
Isoform 8	6e6b.1.A	monomer	0.53	1153-1722	6×CA;	32.30
Assess
Isoform 8	6e6b.1.A	monomer	0.53	678-1310	5×CA;	26.86
Assess
Isoform 8	6vg1.1.A	monomer	0.52	449-988	1×CA;	32.37
Assess
Isoform 8	6vg1.1.A	monomer	0.52	1138-1724	1×CA;	32.11
Assess
Isoform 8	6e6b.1.A	monomer	0.52	467-1099	4×CA;	30.67
Assess
Isoform 8	6vg4.1.A	monomer	0.51	1840-2397	2×CA;	30.23
Assess
Isoform 8	6vg4.1.A	monomer	0.50	277-885	2×CA;	34.08
Assess
Isoform 9	3q2v.1.A	homo-2-mer	0.57	63-601	4×CA;	22.57
Assess
Isoform 9	6e6b.1.A	homo-2-mer	0.56	60-714	7×CA;	27.21
Assess
Isoform 9	5t9t.1.A	homo-2-mer	0.55	166-715	6×CA;	27.17
Assess
Isoform 9	3q2w.1.B	homo-2-mer	0.53	167-711	4×CA;	25.20
Assess
Isoform 9	7a7d.1.H	monomer	0.53	168-712		22.98
Assess
Isoform 9	7a7d.1.A	monomer	0.53	60-607		22.83
Assess
Isoform 9	6c13.1.A	homo-2-mer	0.52	266-813		23.13
Assess
Isoform 9	5erd.1.A	homo-2-mer	0.52	162-712		22.55
Assess
Isoform 9	7a7d.1.E	monomer	0.51	162-712		22.51
Assess
Isoform 9	7a7d.1.A	monomer	0.51	162-712		22.51
Assess
Isoform 9	7a7d.1.D	monomer	0.50	162-712		22.51
Assess

Q9H251 (CAD23_HUMAN) Homo sapiens (Human)

Cadherin-23 UniProtKBInterProSTRINGInteractive Modelling

Available Structures

6 Experimental Structures

12 SWISS-MODEL models

88 SWISS-MODEL models built on isoform sequence

Alignments

Background

Resolution

Cadherin-23 UniProtKB InterPro STRING Interactive Modelling